Canadian Journal of Infectious Diseases and Medical Microbiology Journal

Overview
Identity
View All

publication venue for

Intravenous to oral antimicrobial stepdown therapy at the Henderson Hospital, Hamilton, Ontario 1995
A Prospective Open‐Label Multicentre Trial on the Use of 1 G, Once Daily Ceftriaxone in Lower Respiratory Tract Infections 1994
Antimicrobial treatment of community acquired pneumonia in adults: A conference report 1994
Hospital Acquired Pneumonia: Issues in Therapy 1994
POTENTIAL MANIPULATIONS TO RESTORE ABERRANT MYELOPOIESIS - THE ROLE OF NEW COLONY-STIMULATING FACTORS AND OTHER AGENTS 1992
Clinical Considerations in the Selection of Preexposure Prophylaxis for HIV Prevention in Canada. 2022:1-14. 2022
In-Hospital Macro-, Meso-, and Micro-Drivers and Interventions for Antibiotic Use and Resistance: A Rapid Evidence Synthesis of Data from Canada and Other OECD Countries. 2022:1-11. 2022
CIHR Canadian HIV Trials Network Coinfection and Concurrent Diseases Core Research Group: 2016 Updated Canadian HIV/Hepatitis C Adult Guidelines for Management and Treatment. 2016:1-34. 2016
Case Report of Necrotizing Fasciitis Associated withStreptococcus pneumoniae. 2016:1-4. 2016
HIV Prophylaxis in High Risk Newborns: An Examination of Sociodemographic Factors in an Inner City Context. 2016:1-9. 2016
24^th Annual Canadian Conference on HIV/AIDS Research. 26:4B-5B. 2015
A Venomous Visitor from the Tropics. 26:243-244. 2015
Canadian Public Health Laboratory Network Laboratory Guidelines for the Use of Direct Tests to Detect Syphilis in Canada. 26:13A-17A. 2015
Canadian Public Health Laboratory Network National Syphilis Laboratory Testing Recommendations: Introduction. 26:4A-5A. 2015
Canadian Public Health Laboratory Network laboratory Guidelines for the Diagnosis of Neurosyphilis in Canada. 26:18A-22A. 2015
Canadian Public Health Laboratory Network laboratory Guidelines for the Use of Point‐of‐Care Tests for the Diagnosis of Syphilis in Canada. 26:29A-32A. 2015
Hepatitis C Virus Seroconversion among Hiv‐Positive Men Who Have Sex With Men With No History of Injection Drug Use: Results from a Clinical Hiv Cohort. 26:17-22. 2015
Prevalence of Antimicrobial Use in a Network of Canadian Hospitals in 2002 and 2009. 26:85-89. 2015
Public Health Response to a Large‐scale Endoscopy Infection Control Lapse in a Nonhospital Clinic. 26:77-84. 2015
A Brief Report of West Nile Virus Neuroinvasive Disease in the Summer of 2012 in Hamilton, Ontario. 25:24-26. 2014
An Atypical Cause of Atypical Chest Pain. 25:253-254. 2014
Characterization of Methicillin‐Resistant Staphylococcus aureus Isolates from Patients with Persistent or Recurrent Bacteremia. 25:83-86. 2014
Fever in the Returning Traveller: A Forgotten Culprit. 25:194-195. 2014
Melioidosis in a Returned Traveller. 25:225-226. 2014
Prevention of Vertical HIV Transmission and Management of the HIV‐Exposed Infant in Canada in 2014. 25:75-77. 2014
Real-Time Polymerase Chain Reaction for Microbiological Diagnosis of Parapneumonic Effusions in Canadian Children. 25:151-154. 2014
The Prospective Antifungal Therapy Alliance^® Registry: A Two‐Centre Canadian Experience. 25:17-23. 2014
Triage and Protocol Recommendations for the Parasitology Laboratory Based on an Epidemiological Investigation of Parasite Diagnostics in Ontario Laboratories. 25:305-310. 2014
Aerococcus viridansNative Valve Endocarditis. 24:155-158. 2013
Bats, Fever and Adenopathy – What Is the Link?. 24:35-37. 2013
Emergency Department Surveillance as a Proxy For The Prediction of Circulating Respiratory Viral Disease in Eastern Ontario. 24:150-154. 2013
Erratum: Emergency department Surveillance as a proxy for the Prediction of circulating respiratory viral disesase in Estern Ontario (Can J Infact Dis Med Microbiol (2013) 24:3 (150-154)). 24:240. 2013
Increasing HIV Subtype Diversity and Its Clinical Implications in a Sentinel North American Population. 24:69-73. 2013
Influence of 16S Ribosomal RNA Gene Polymerase Chain Reaction and Sequencing on Antibiotic Management of Bone and Joint Infections. 24:85-88. 2013
A Case of Indolent Endocarditis. 23:e51-e52. 2012
Cardiac Device Infection due to Streptococcus pneumoniae. 23:135-136. 2012
Daptomycin‐Nonsusceptible, Vancomycin‐Intermediate, Methicillin‐Resistant Staphylococcus aureus Endocarditis. 23:e48-e50. 2012
Successful Use of Posaconazole to Treat Invasive Cutaneous Fungal Infection in a Liver Transplant Patient on Sirolimus. 23:e44-e47. 2012
A 10‐Year Retrospective Review of Salmonella Infections at the Children’s Hospital in London, Ontario. 21:78-82. 2010
Systemic Therapy of New World Cutaneous Leishmaniasis: A Case Report and Review Article. 21:e79-e83. 2010
Genetically Typed Community‐Acquired Methicillin‐Resistant Staphylococcus aureus in a Canadian Hospital. 20:e113-e114. 2009
Laboratory Diagnosis of Mumps in a Partially Immunized Population: The Nova Scotia Experience. 20:e157-e162. 2009
Research Preparedness Paves the Way to Respond to Pandemic H1N1 2009 Influenza Virus. 20:63-63. 2009
A Case of Necrotizing Fasciitis due to Streptococcus pneumoniae Serotype 5 in Saskatchewan. 19:69-71. 2008
A Preliminary Guideline for the Assignment of Methicillin‐Resistant Staphylococcus aureus to a Canadian Pulsed‐Field Gel Electrophoresis Epidemic Type Using spa Typing. 19:273-281. 2008
A Traveller in Time: Phylogenetic Analysis to Identify a Disseminated Infection Acquired 30 Years Earlier. 19:313-315. 2008
A traveler in time: phylogenetic analysis diagnoses the first case of reactivated sub-acute disseminated African histoplasmosis in an immunocompromised host from Tanzania.. 19:313-315. 2008
HAP/VAP: Simpler May Be Cetter. 19:11-11. 2008
Fever of Unknown Origin in a Migrant Farm Worker from Mexico: History, Her Story and His Story. 18:368-369. 2007
Pulmonary Hyalinizing Granuloma in HIV/AIDS. 18:305-307. 2007
The Diagnosis of Genital Herpes – Beyond Culture: An Evidence‐Based Guide for the Utilization of Polymerase Chain Reaction and Herpes Simplex Virus Type‐Specific Serology. 18:233-240. 2007
Antimicrobial Resistance among Salmonella and Shigella Isolates in Five Canadian Provinces (1997 to 2000). 17:243-250. 2006
Canadian Consensus Recommendations for the Optimal Use of Enfuvirtide in HIV/AIDS Patients. 17:155-163. 2006
Canadian Laboratory Standards for Sexually Transmitted Infections: Best Practice Guidelines. 16:11-11. 2005
Outbreaks of Infection Caused by Community‐Acquired Methicillin‐Resistant Staphylococcus aureus in a Canadian Correctional Facility. 16:343-348. 2005
Overwhelming Pulmonary Infection after a Tobogganing Accident. 16:253-254. 2005
Syndromes Associated with Sexually Transmitted Infections. 16:13-14. 2005
The Evaluation of Diagnostic Tests for Sexually Transmitted Infections. 16:80-82. 2005
The Laboratory Diagnosis of Sexually Transmitted Infections in Cases of Sexual Assault and Abuse. 16:63-64. 2005
The Laboratory Diagnosis of Syphilis. 16:45-51. 2005
The laboratory diagnosis of Chlamydia trachomatis infections. 16:39-44. 2005
Clinical Outcome with Oral Linezolid and Rifampin Following Recurrent Methicillin‐Resistant Staphylococcus aureus Bacteremia Despite Prolonged Vancomycin Treatment. 15:97-100. 2004
The Management of Infection and Colonization due to Methicillin‐Resistant Staphylococcus aureus: A CIDS/CAMM Position Paper. 15:39-48. 2004
Antimicrobials in Acute Exacerbations of Chronic Obstructive Pulmonary Disease ‐ An Analysis of the Time to Next Exacerbation Before and After Implementation of Standing Orders. 14:254-259. 2003
Safety of Fluoroquinolones: An Update. 13:54-61. 2002
The Emerging Epidemiology of VRE in Canada: Results of the CNISP Passive Reporting Network, 1994 to 1998. 12:364-370. 2001
Experience with a Special Outpatient Antimicrobial Program at McMaster University Medical Centre in 1997. 11:15a-16a. 2000
Summary of Canadian Guidelines for the Initial Management of Community‐Acquired Pneumonia: An Evidence‐Based Update by the Canadian Infectious Disease Society and the Canadian Thoracic Society. 11:237-248. 2000
Varicella Susceptibility in a Canadian Population. 11:249-253. 2000
A Cross‐Canada Surveillance of Antimicrobial Resistance in Respiratory Tract Pathogens. 10:128-133. 1999
Antibiotic and Oral Contraceptive Drug Interactions: Is There a Need for Concern?. 10:429-433. 1999
Antimicrobial Regimens Prescribed by Canadian Physicians for Chemotherapy‐Induced Febrile Neutropenic Episodes. 10:353-357. 1999
In Vitro Activity of Cefepime against Multidrug‐Resistant Gram‐Negative Bacilli, Viridans Group Streptococci and Streptococcus pneumoniae from a Cross‐Canada Surveillance Study. 10:122-127. 1999
Addition information concerning the comparison of imipenem and meropenem [1] (multiple letters). 9:322-326. 1998
An Integrated Approach to Antimicrobial Stewardship in the Hospital Setting. 9:7c-16c. 1998
Classification, Diagnosis and Treatment of Sinusitis: Evidence‐Based Clinical Practice Guidelines. 9:3b-24b. 1998
Current Indications for the Use of Clindamycin: A Critical Review. 9:22-28. 1998
How Much Does It Cost to Manage Paediatric Tuberculosis? One‐Year Experience from The Hospital for Sick Children. 9:354-358. 1998
Imipenem and Meropenem: Comparison of In Vitro Activity, Pharmacokinetics, Clinical Trials and Adverse Effects. 9:215-228. 1998
Decision Analysis Modelling of Costs and Outcomes following Cefepime Monotherapy in Canada. 8:19-27. 1997
Piperacillin/tazobactam. 8:79-84. 1997
Rubella Antibody Levels in School‐Aged Children in Newfoundland: Implications for a Two‐Dose Rubella Vaccination Strategy. 8:85-88. 1997
Itraconazole: An oral systemic antifungal triazole. 7:366-369. 1996
Management of diabetic foot infection: A position paper. 7. 1996
A Multidisciplinary Hospital‐based Antimicrobial Use Program: Impact on Hospital Pharmacy Expenditures and Drug Use. 7:104-109. 1996
Antimicrobial Activity of Ceftriaxone Compared with Cefotaxime in the Presence of Serum Albumin. 6:21-27. 1995
Intravenous to Oral Antimicrobial Stepdown Therapy at the Henderson Hospital, Hamilton, Ontario. 6:23a-24a. 1995
Sequential Antibiotic Therapy: Effective Cost Management and Patient Care. 6:306-315. 1995
A prospective Comparison of Porta‐Sonic and Fisoneb Ultrasonic Nebulizers for Administering Aerosol Pentamidine. 5:62-66. 1994
Response to “Treatment Guidelines for Nosocomial Pneumonia: Agreeing to Disagree”. 5:56-57. 1994
A Prospective Randomized Trial of Imipenem‐Cilastatin Versus Clindamycin/Tobramycin in the Treatmentof Intra‐Abdominal and Pelvic Infections. 4:279-287. 1993
Antimicrobial Treatment of Community Acquired Pneumonia in Adults: A Conference Report. 4:25-28. 1993
Initial Antimicrobial Treatment of Hospital Acquired Pneumonia in Adults: A Conference Report. 4:317-321. 1993
The Renaissance of the Macrolides: New and Changing Roles in Infectious Diseases. 4:1-4. 1993
Reduction in Clinical Response to Empiric Antimicrobial Therapy of Febrile Granulocytopenic Patients Receiving TMP/SMX Infection Prophylaxis. 3:235-239. 1992
Pneumococcal Endometritis with Peritonitis: Case Report and Review of the Literature. 2:161-164. 1991
The Potential Role of Recombinant Hematopoietic Colony‐Stimulating Factors in Preventing Infections in the Immunocompromised Host. 2:74-88. 1991

has subject area